Novartis Ends Hypertension DTC Campaign After FDA Objects To Diovan Link
Novartis has discontinued its unbranded direct-to-consumer advertising campaign on hypertension awareness following objections by FDA
Novartis has discontinued its unbranded direct-to-consumer advertising campaign on hypertension awareness following objections by FDA